192 related articles for article (PubMed ID: 11241321)
1. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines.
Woo DK; Kim HS; Lee HS; Kang YH; Yang HK; Kim WH
Int J Cancer; 2001 Mar; 95(2):108-13. PubMed ID: 11241321
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the beta-catenin gene in gastric carcinomas.
Sasaki Y; Morimoto I; Kusano M; Hosokawa M; Itoh F; Yanagihara K; Imai K; Tokino T
Tumour Biol; 2001; 22(2):123-30. PubMed ID: 11125285
[TBL] [Abstract][Full Text] [Related]
3. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
4. Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis.
Nabais S; Machado JC; Lopes C; Seruca R; Carneiro F; Sobrinho-Simões M
Int J Surg Pathol; 2003 Jan; 11(1):1-9. PubMed ID: 12598910
[TBL] [Abstract][Full Text] [Related]
5. Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.
Tziortzioti V; Ruebel KH; Kuroki T; Jin L; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(2):125-36. PubMed ID: 11579678
[TBL] [Abstract][Full Text] [Related]
6. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer.
Ebert MP; Fei G; Kahmann S; Müller O; Yu J; Sung JJ; Malfertheiner P
Carcinogenesis; 2002 Jan; 23(1):87-91. PubMed ID: 11756228
[TBL] [Abstract][Full Text] [Related]
7. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.
Clements WM; Wang J; Sarnaik A; Kim OJ; MacDonald J; Fenoglio-Preiser C; Groden J; Lowy AM
Cancer Res; 2002 Jun; 62(12):3503-6. PubMed ID: 12067995
[TBL] [Abstract][Full Text] [Related]
8. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
9. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
10. Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion.
Miyazawa K; Iwaya K; Kuroda M; Harada M; Serizawa H; Koyanagi Y; Sato Y; Mizokami Y; Matsuoka T; Mukai K
Virchows Arch; 2000 Nov; 437(5):508-13. PubMed ID: 11147171
[TBL] [Abstract][Full Text] [Related]
11. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
12. Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome.
Grabsch H; Takeno S; Noguchi T; Hommel G; Gabbert HE; Mueller W
Histopathology; 2001 Aug; 39(2):141-9. PubMed ID: 11493330
[TBL] [Abstract][Full Text] [Related]
13. beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.
Suriano G; Vrcelj N; Senz J; Ferreira P; Masoudi H; Cox K; Nabais S; Lopes C; Machado JC; Seruca R; Carneiro F; Huntsman DG
Genes Chromosomes Cancer; 2005 Mar; 42(3):238-46. PubMed ID: 15609344
[TBL] [Abstract][Full Text] [Related]
14. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):230-7. PubMed ID: 12966349
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
Garcia-Rostan G; Camp RL; Herrero A; Carcangiu ML; Rimm DL; Tallini G
Am J Pathol; 2001 Mar; 158(3):987-96. PubMed ID: 11238046
[TBL] [Abstract][Full Text] [Related]
16. Detection and analysis of beta-catenin mutations in prostate cancer.
Chesire DR; Ewing CM; Sauvageot J; Bova GS; Isaacs WB
Prostate; 2000 Dec; 45(4):323-34. PubMed ID: 11102958
[TBL] [Abstract][Full Text] [Related]
17. Alterations of E-cadherin and beta-catenin in gastric cancer.
Huiping C; Kristjansdottir S; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
BMC Cancer; 2001; 1():16. PubMed ID: 11747475
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
Zhou YN; Li M
Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
[TBL] [Abstract][Full Text] [Related]
19. Loss of beta-catenin expression in metastatic gastric cancer.
Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P
J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245
[TBL] [Abstract][Full Text] [Related]
20. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.
Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA
Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]